These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 19687355)

  • 1. Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease.
    Chung AW; Yang HH; Kim JM; Sigrist MK; Chum E; Gourlay WA; Levin A
    Circulation; 2009 Sep; 120(9):792-801. PubMed ID: 19687355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential microvasculature dysfunction in living kidney donor transplant recipients: nondialyzed versus dialyzed chronic kidney disease patients.
    Chung AW; Yang HH; Sigrist MK; Chum E; Booth AD; Gourlay WA; Levin A
    J Vasc Res; 2010; 47(2):128-38. PubMed ID: 19729959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease.
    Chung AW; Yang HH; Sigrist MK; Brin G; Chum E; Gourlay WA; Levin A
    Cardiovasc Res; 2009 Dec; 84(3):494-504. PubMed ID: 19617223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in human type 2 diabetic arterial vasculature.
    Chung AW; Hsiang YN; Matzke LA; McManus BM; van Breemen C; Okon EB
    Circ Res; 2006 Jul; 99(2):140-8. PubMed ID: 16778129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
    Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E
    Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease.
    Chang HR; Yang SF; Li ML; Lin CC; Hsieh YS; Lian JD
    Clin Chim Acta; 2006 Apr; 366(1-2):243-8. PubMed ID: 16313894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
    David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
    Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased matrix metalloproteinase 2 activity in the human internal mammary artery is associated with ageing, hypertension, diabetes and kidney dysfunction.
    Chung AW; Booth AD; Rose C; Thompson CR; Levin A; van Breemen C
    J Vasc Res; 2008; 45(4):357-62. PubMed ID: 18332634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease.
    Sigrist MK; Taal MW; Bungay P; McIntyre CW
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1241-8. PubMed ID: 17928470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?
    Peiskerová M; Kalousová M; Kratochvílová M; Dusilová-Sulková S; Uhrová J; Bandúr S; Malbohan IM; Zima T; Tesar V
    Kidney Blood Press Res; 2009; 32(4):276-83. PubMed ID: 19797911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of serum matrix metalloproteinase-3 in haemodialysis patients with dialysis-related amyloidosis.
    Naganuma T; Sugimura K; Uchida J; Tashiro K; Yoshimura R; Takemoto Y; Nakatani T
    Nephrology (Carlton); 2008 Apr; 13(2):104-8. PubMed ID: 18275497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
    Martinez ML; Castro MM; Rizzi E; Fernandes K; Demacq C; Bendhack LM; Gerlach RF; Tanus-Santos JE
    Eur J Pharmacol; 2008 Sep; 591(1-3):224-30. PubMed ID: 18634778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis.
    Shroff RC; McNair R; Figg N; Skepper JN; Schurgers L; Gupta A; Hiorns M; Donald AE; Deanfield J; Rees L; Shanahan CM
    Circulation; 2008 Oct; 118(17):1748-57. PubMed ID: 18838561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular calcification and disordered mineral metabolism in dialysis patients.
    Kalpakian MA; Mehrotra R
    Semin Dial; 2007; 20(2):139-43. PubMed ID: 17374088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between fetuin-A concentration, elevated levels of inflammatory markers, and arterial wall stiffness in end-stage kidney disease.
    Kuźniar J; Porazko T; Klinger M
    J Ren Nutr; 2008 Jan; 18(1):83-6. PubMed ID: 18089450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of matrix metalloproteinase-2 in the development of medial layer vascular calcification in uremic rats.
    Kumata C; Mizobuchi M; Ogata H; Koiwa F; Kondo F; Kinugasa E; Akizawa T
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():18-22. PubMed ID: 21595847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9.
    Chung AW; Yang HH; Radomski MW; van Breemen C
    Circ Res; 2008 Apr; 102(8):e73-85. PubMed ID: 18388324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor correlation between coronary artery calcification and obstructive coronary artery disease in an end-stage renal disease patient.
    Tong LL; Mehrotra R; Shavelle DM; Budoff M; Adler S
    Hemodial Int; 2008 Jan; 12(1):16-22. PubMed ID: 18271835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exercise training on aortic tone in chronic renal insufficiency.
    Shelkovnikov S; Summers SM; Elahimehr R; Adams G; Purdy RE; Vaziri ND
    Am J Hypertens; 2008 May; 21(5):564-9. PubMed ID: 18437148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension.
    Castro MM; Rizzi E; Rodrigues GJ; Ceron CS; Bendhack LM; Gerlach RF; Tanus-Santos JE
    Free Radic Biol Med; 2009 May; 46(9):1298-307. PubMed ID: 19248829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.